Omeprazol Medical Valley (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Medical Valley, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid production and is used to manage conditions such as gastro‑esophageal reflux disease, peptic ulcer disease, and ulcer prevention in patients taking NSAIDs.

GNH USA supplies Omeprazol Medical Valley as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution.

Omeprazole is a proton pump inhibitor used to treat acid‑related gastrointestinal disorders.

Gastro‑esophageal reflux disease (GERD): reduces symptoms and promotes healing of esophageal irritation. Peptic ulcer disease: facilitates ulcer healing by decreasing gastric acidity. NSAID‑induced ulcer prophylaxis: prevents ulcer formation in patients receiving non‑steroidal anti‑inflammatory drugs. Helicobacter pylori eradication (in combination therapy): enhances eradication rates when used with antibiotics and a bismuth compound.

Omeprazole may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Headache: mild to moderate headache reported. - Diarrhea: loose stools or increased bowel movements. - Nausea: feeling of sickness or upset stomach. - Abdominal pain: discomfort or cramps in the stomach area. - Flatulence: increased gas production. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis due to bacterial overgrowth. - Acute interstitial nephritis: kidney inflammation presenting with rash and fever. - Stevens‑Johnson syndrome: rare severe skin reaction with blistering. - Bone fracture: increased risk of hip or wrist fractures with long‑term use.

When prescribing omeprazole, several precautions should be considered to ensure safe use.

- Assess renal function: dose adjustment may be needed in severe renal impairment. - Evaluate for CYP2C19 polymorphisms: altered metabolism can affect drug levels. - Monitor for magnesium deficiency: long‑term therapy may cause hypomagnesemia. - Use with caution in elderly: increased risk of fractures and infections. - Avoid abrupt discontinuation: may cause rebound acid hypersecretion; taper if possible. - Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Omeprazole can affect the pharmacokinetics of several medicines, leading to clinically relevant interactions.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, may increase cardiovascular risk. - Atazanavir: decreased absorption, loss of antiviral efficacy. - Dasatinib: lowered plasma concentrations, reduced therapeutic effect.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, monitor coagulation. - Phenytoin: increased serum levels, watch for toxicity. - Methotrexate (high dose): elevated levels, monitor renal function. - Digoxin: modest increase in concentration, assess for toxicity.